ing. D.F. Samplonius

Faculteit Medische Wetenschappen/UMCG

Telefoon:

050 361 8018

E-mail:

d.f.samplonius umcg.nl

ORCID Research Portal

Publicaties

Enhancing the Anticancer Activity of a Carcinoma-Directed Peptide-HLA-I Fusion Protein by Armoring with Mutein IFNα

Samplonius, D. F., van Wijngaarden, A. P., Koll, L., Ke, X. & Helfrich, W., 29-mrt.-2025, In: International Journal of Molecular Sciences. 26, 7, 19 blz., 3178.

Onderzoeksoutput › › peer review

Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein

Volarić, J., van der Heide, N. J., Mutter, N. L., Samplonius, D. F., Helfrich, W., Maglia, G., Szymanski, W. & Feringa, B. L., 16-feb.-2024, In: ACS chemical biology. 19, 2, blz. 451–461 11 blz., 3c00640.

Onderzoeksoutput › › peer review

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer

Ploeg, E. M., Britsch, I., van Wijngaarden, A. P., Ke, X., Hendriks, M. A. J. M., Samplonius, D. F. & Helfrich, W., jul.-2023, In: Cancers. 15, 14, 15 blz., 3651.

Onderzoeksoutput › › peer review

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR

Ploeg, E. M., Samplonius, D. F., Xiong, X., Ke, X., Hendriks, M. A. J. M., Britsch, I., Van Wijngaarden, A. P., Zhang, H. & Helfrich, W., 21-sep.-2023, In: Journal for immunotherapy of cancer. 11, 9, 15 blz., e006837.

Onderzoeksoutput › › peer review

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells

Britsch, I., van Wijngaarden, A. P., Ke, X., Hendriks, M. A. J. M., Samplonius, D. F., Ploeg, E. M. & Helfrich, W., 2023, In: OncoImmunology. 12, 1, 2207868.

Onderzoeksoutput › › peer review

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET

Helbert, H., Ploeg, E. M., Samplonius, D. F., Blok, S. N., Antunes, I. F., Böhmer, V. I., Luurtsema, G., Dierckx, R. A. J. O., Feringa, B. L., Elsinga, P. H., Szymanski, W. & Helfrich, W., 3-mrt.-2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 1, 11 blz., 3.

Onderzoeksoutput › › peer review

Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles

Ploeg, E. M., Ke, X., Britsch, I., Hendriks, M. A. J. M., Van der Zant, F. A., Kruijff, S., Samplonius, D. F., Zhang, H. & Helfrich, W., 28-nov.-2021, In: Cancer letters. 521, blz. 109-118 10 blz.

Onderzoeksoutput › › peer review

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRP alpha axis

Hendriks, M. A. J. M., Britsch, I., Ke, X., van Wijngarden, A. P., Samplonius, D. F., Ploeg, E. M. & Helfrich, W., 20-nov.-2021, In: OncoImmunology. 10, 1, 14 blz., 2005344.

Onderzoeksoutput › › peer review

Corrigendum: Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of F-18-Labeled PSMA-Tracers for Prostate Cancer Imaging (vol 26, pg 10871, 2020)

Böhmer, V. I., Szymanski, W., van den Berg, K.-O., Mulder, C., Kobauri, P., Helbert, H., van der Born, D., Reeβing, F., Huizing, A., Klopstra, M., Samplonius, D. F., Antunes, I. F., Sijbesma, J. W. A., Luurtsema, G., Helfrich, W., Visser, T. J., Feringa, B. L. & Elsinga, P. H., 21-apr.-2021, In: Chemistry. 27, 23, blz. 6993-6993 1 blz.

Onderzoeksoutput

Synthesis and Evaluation of F-18-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16 beta-F-18-Fluoro-5 alpha-Dihydrotestosterone

Farinha Antunes, I., Dost, R., Hoving, H. D., van Waarde, A., Dierckx, R. A., Samplonius, D. F., Helfrich, W., Elsinga, P. H., de Vries, E. F. & de Jong, I. J., 1-aug.-2021, In: Journal of Nuclear Medicine. 62, 2, blz. 1140-1145 6 blz.

Onderzoeksoutput › › peer review

Alle (41) publicaties

Bekijk volledig onderzoeksprofiel